Product Overview
Thymosin Alpha-1 is a 28-amino-acid peptide supplied by PeptaCo for qualified laboratory research. It is a naturally occurring thymic peptide involved in immune system modulation research. Thymosin Alpha-1 is widely referenced in immunology investigations and T-cell biology studies.
Key Product Details
- Product Name: Thymosin Alpha-1
- Specification: As listed per catalog variant
- Product Form: Lyophilized powder
- Category: Immune Research Peptides
- Peptide Length: 28 amino acids
Chemical Identity
Thymosin Alpha-1 is a 28-amino-acid peptide derived from the N-terminal region of prothymosin alpha. The sequence is: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH. Molecular Weight: ~3108 Da. PubChem CID: 16134166. This listing covers Thymosin Alpha-1 in multiple specifications (5mg, 10mg).
Research Context
Thymosin Alpha-1 is extensively studied in immunology research for its role in T-cell differentiation and immune response modulation. It is commonly referenced in investigations of immune cell function, cytokine regulation, and thymic peptide biology. PeptaCo supplies Thymosin Alpha-1 in multiple specifications to support diverse research requirements.
Storage and Handling
Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.
Documentation and Quality
Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.
Important Notice
This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.
